Cargando…
The evaluation of the utility of the GENECUBE HQ SARS-CoV-2 for anterior nasal samples and saliva samples with a new rapid examination protocol
INTRODUCTION: GENECUBE(®) is a rapid molecular identification system, and previous studies demonstrated that GENECUBE(®) HQ SARS-CoV-2 showed excellent analytical performance for the detection of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) with nasopharyngeal samples. However, other...
Autores principales: | Naito, Asami, Kiyasu, Yoshihiko, Akashi, Yusaku, Sugiyama, Akio, Michibuchi, Masashi, Takeuchi, Yuto, Notake, Shigeyuki, Nakamura, Koji, Ishikawa, Hiroichi, Suzuki, Hiromichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719657/ https://www.ncbi.nlm.nih.gov/pubmed/34972195 http://dx.doi.org/10.1371/journal.pone.0262159 |
Ejemplares similares
-
A Prospective Evaluation of the Analytical Performance of GENECUBE(®) HQ SARS-CoV-2 and GENECUBE(®) FLU A/B
por: Kiyasu, Yoshihiko, et al.
Publicado: (2021) -
Clinical evaluation of the rapid nucleic acid amplification point-of-care test (Smart Gene SARS-CoV-2) in the analysis of nasopharyngeal and anterior nasal samples()
por: Kiyasu, Yoshihiko, et al.
Publicado: (2022) -
Diagnostic performance of a novel digital immunoassay (RapidTesta SARS-CoV-2): A prospective observational study with nasopharyngeal samples
por: Suzuki, Hiromichi, et al.
Publicado: (2022) -
Evaluation and clinical implications of the time to a positive results of antigen testing for SARS-CoV-2
por: Akashi, Yusaku, et al.
Publicado: (2022) -
Prospective analytical performance evaluation of the QuickNavi™-COVID19 Ag for asymptomatic individuals()
por: Kiyasu, Yoshihiko, et al.
Publicado: (2021)